| name | endo-igf1-typical-manifestations |
| description | Recommends measuring serum IGF-1 to screen for acromegaly in patients presenting with typical acral and facial manifestations such as enlarging ring or shoe size, macroglossia, or frontal bossing. Trigger phrases include “acral enlargement,” “facial coarsening,” “prognathism,” or “spade‑like hands” prompting IGF-1 measurement. |
Measure IGF-1 in typical acromegaly manifestations
STEP 1 — Gather Information
Ask about progressive acral changes (ring, shoe, glove size), facial changes (coarsening, prognathism, forehead prominence), symptoms (headache, visual field changes, arthralgia, fatigue), and screen for comorbidities (sleep apnea, diabetes, hypertension, carpal tunnel syndrome). If typical features are present, proceed to IGF-1 measurement.
STEP 2 — Rule In / Rule Out
Are typical acromegaly manifestations (acral/facial features) present?
- Yes: Measure serum IGF-1 using an age‑adjusted assay.
- No: Consider alternative diagnoses; IGF-1 measurement is not routinely indicated unless atypical presentation with associated conditions (e.g., unexplained diabetes, sleep apnea).
STEP 3 — Classify or Stratify
Interpret IGF-1 against age‑adjusted normal limits for the specific assay.
- Elevated (> upper limit of normal): Proceed to confirmatory testing (GH suppression).
- Normal or low: Acromegaly unlikely; reassess clinically, consider assay pitfalls, and monitor for symptom progression.
STEP 4 — Decide
If IGF-1 is elevated, order an oral glucose tolerance test for GH suppression and obtain a pituitary MRI.
If IGF-1 is normal, pursue other diagnoses, repeat IGF-1 only if clinical suspicion remains high or if confounding factors (renal/hepatic failure, hypothyroidism) are suspected.
Clinical Guardrails / Mimics / Pitfalls
IGF-1 assays show inter‑laboratory variability; always use age‑adjusted norms. False‑low results may occur in renal or hepatic failure, untreated hypothyroidism, malnutrition, or pregnancy. Do not rely on random GH alone for screening. Avoid delaying MRI when IGF-1 is clearly elevated. Beware of assay interference from heterophilic antibodies or rheumatoid factor.
Concrete Clinical Example
A 45‑year‑old woman notes her ring size increased from 6 to 8 over 18 months, shoe size increased, and she reports new‑onset jaw protrusion and frontal bossing with snoring and morning headaches. Serum IGF-1 is 2.5 × the age‑adjusted upper limit of normal. Proceed to OGTT for GH suppression and pituitary MRI.
Source: Acromegaly: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2014, doi:10.1210/jc.2014-2700
